Measurement of the Systemic Inflammatory Response Predicts Cancer-Specific and Non-Cancer Survival in Patients With Cancer

This publication has 15 references indexed in Scilit:

• Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer
  Annals of Surgical Oncology, 2000
• Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight Loss
  Nutrition and Cancer, 2000
• Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study Commentary: Why do doctors overestimate? Commentary: Prognoses should be based on proved indices not intuition
  BMJ, 2000
• Acute-Phase Proteins and Other Systemic Responses to Inflammation
  New England Journal of Medicine, 1999
• C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
  Circulation, 1999
• The value of acute-phase protein measurements after curative gastric cancer surgery.
  Archives of Surgery, 1999
• CYTOKINE LEVELS (IL-6 AND IFN-γ), ACUTE PHASE RESPONSE AND NUTRITIONAL STATUS AS PROGNOSTIC FACTORS IN LUNG CANCER
  Cytokine, 1999
• Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer
  The American Journal of Surgery, 1998
• Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery
  European Journal of Surgical Oncology, 1996
• A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery
  The American Journal of Surgery, 1995